By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

A new machine-learning approach for prostate-specific membrane antigen (PSMA) treatment of metastatic castration-resistant prostate cancer (mCRPC) could estimate radiation dose to tumors and healthy ...

The man on the other end was J. Bruce Hunsicker, an Akron-based lawyer with prostate cancer who had started a foundation to raise money for research into the disease. He wanted to connect with Dr.

RICHMOND, Va. (January 20, 2026) – Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently awarded a $1.8 million, 3-year grant from the ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

(WHTM) — A treatment option for prostate cancer patients is now available in the Midstate. The UPMC Hillman Cancer Center in Harrisburg can now provide HDR, or high-dose rate prostate brachytherapy.

For men who have a detectable PSA of 0.5 ng/mL or less after radical prostatectomy and before salvage radiation therapy, hormone therapy may provide no overall survival or metastasis-free survival ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether combining precision radiation with a targeted radioactive therapy drug can ...